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Prior biochemical analysis of the heterodimeric vaccinia virus mRNA capping enzyme suggests roles not
only in mRNA capping but also in early viral gene transcription termination and intermediate viral gene
transcription initiation. Prior phenotypic characterization of Dts36, a temperature sensitive virus mutant
affecting the large subunit of the capping enzyme was consistent with the multifunctional roles of the
capping enzyme in vivo. We report a biochemical analysis of the capping enzyme encoded by Dts36. Of
the three enzymatic activities required for mRNA capping, the guanylyltransferase and methyltransferase
activities are compromised while the triphosphatase activity and the D12 subunit interaction are unaf-
fected. The mutant enzyme is also defective in stimulating early gene transcription termination and
intermediate gene transcription initiation in vitro. These results conﬁrm that the vaccinia virus mRNA
capping enzyme functions not only in mRNA capping but also early gene transcription termination and
intermediate gene transcription initiation in vivo.
& 2015 Elsevier Inc. All rights reserved.Introduction
The poxvirus vaccinia contains a 200 kb dsDNA genome
encoding approximately 200 annotated gene products, and repli-
cates in the cell cytoplasm (Moss, 2013). The cytoplasmic site of
replication demands that the virus encode and package in the
virion an entire complement of enzymes required for production
of capped and polyadenylated mRNA, including a multisubunit
RNA polymerase, a heterodimeric poly(A) polymerase and a het-
erodimeric mRNA capping enzyme. For this reason, vaccinia has a
long been utilized as a simple model system for understanding
basic mechanisms of mRNA metabolism. Interestingly, despite a
relatively large coding capacity, vaccinia has nevertheless appar-
ently evolved to economize on genetic content by elaborating
multiple roles for several viral enzymes. Notable in this regard is
the viral mRNA capping enzyme, which serves not only to cap the
mRNA 50 end, but also as an early gene transcription termination.
ation Dr, Alachua, FL 32615,
.
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, PA 17222.factor and an intermediate gene transcription initiation factor.
Understanding the mechanisms of this multifunctionality is of
intrinsic interest in the context of virus biology and evolution.
Transcription during vaccinia infection is regulated to yield
three waves of gene expression: early, intermediate and late
(Broyles, 2003). The viral RNA polymerase exists in two forms, one
speciﬁc for early gene transcription, and one for intermediate and
late (together called postreplicative) gene transcription. Both
forms of the RNA polymerase contain eight core subunits. The core
enzyme transcribes postreplicative genes. The early gene-speciﬁc
form of the RNA polymerase contains an additional subunit,
encoded by gene H4, which interacts with an early promoter-
binding viral early transcription factor (Yang and Moss, 2009).
Early mRNAs are synthesized from infecting virion core particles
using transcription and mRNA modiﬁcation enzymes packaged in
the virion. Early transcripts encode both viral DNA replication
enzymes and intermediate transcription factors, which together
with newly synthesized viral RNA polymerase activate transcrip-
tion from intermediate gene promoters on replicating viral DNA
released during uncoating of the virion cores. Intermediate genes
encode late transcription factors which in turn activate transcrip-
tion from late gene promoters. Late genes encode virion structural
proteins plus the enzymes required for early gene transcription,
which are packaged into maturing virions for the subsequent
round of infection.
Fig. 1. Structure of the vaccinia virus capping enzyme. Ribbon diagram repre-
sentation of the structure of CE. The three domains of the large D1 subunit are
represented in different colors. The TPase domain (residues 1–225) is blue, the
GTase domain (residues 226–545) is green, and the MTase domain (residues 548–
844) is red. The small D12 subunit is yellow. The bound S-adenosyl-L-homocysteine
in the MTase active site is shown in stick models colored by element. Gly 705,
which is replaced with Asp in the Dts36 mutant, is depicted in space-ﬁlling models
colored light green.
J. Tate et al. / Virology 487 (2016) 27–4028The viral mRNA capping enzyme (CE) is comprised of two
subunits of 97 kDa and 33 kDa, the products of gene D1 and D12
respectively (Martin et al., 1975; Morgan et al., 1984; Niles et al.,
1989; Guo and Moss, 1990). Biochemical and genetic analysis of
the enzyme coupled with a recent crystal structure (Kyrieleis et al.,
2014) (Fig. 1) reveal three separate and distinct catalytic domains
in the D1 subunit which together carry out the three reactions
(Martin and Moss, 1975, 1976; Shuman and Hurwitz, 1981)
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The ﬁrst reaction, removal of the gamma phosphate from the
triphosphorylated RNA to yield a 50 diphosphorylated RNA, is
catalyzed by the N-terminal RNA triphosphatase (TPase) domain of
D1 (Yu and Shuman, 1996; Myette and Niles, 1996a; Gong and
Shuman, 2003). The second reaction, addition of a GMP to the 50
diphosphorylated RNA in a 50–50 linkage to yield an unmethylated
cap structure, proceeds through a covalent enzyme GMP complex
(Shuman and Hurwitz, 1981) and is catalyzed by the internal
guanylyltransferase domain (GTase) of D1 (Niles and Christen,
1993; Cong and Shuman, 1995; Myette and Niles, 1996b). The third
reaction, transfer of a methyl group from S-adenosylmethionine to
the 7 position of the cap guanine to yield a cap 0 structure and
S-adenosylhomocysteine, is catalyzed by the C-terminal methyl-
transferase domain (MTase) of D1 (Higman et al., 1994; Mao and
Shuman, 1994). The D12 subunit forms a stable complex with the
methyltransferase domain of D1. D12 has no known enzymatic
activity but serves to stimulate the otherwise relatively weak
intrinsic methyltransferase activity of D1.
The D1/D12 heterodimer is a required cofactor for viral early
gene transcription termination (Shuman et al., 1987; Luo et al.,
1991). Early gene transcription termination is a sequence speciﬁcevent triggered by the sequence U5NU found 20–50 nt upstream
of early gene 30 ends (before polyadenylation) (Yuen and Moss,
1987). During viral early gene transcription termination, the
sequence U5NU is recognized by CE via the N-terminal TPase
domain of D1 (Christen et al., 2008). Termination itself is catalyzed
by a DNA-dependent nucleoside triphosphate phosphohydrolase
(NPHI, gene D11), which interacts with the early form of the RNA
polymerase through contacts with the early gene speciﬁc H4
subunit (Deng and Shuman, 1996, 1998; Christen et al., 1998;
Mohamed and Niles, 2000). CE can induce pausing by elongating
RNA polymerase, which could theoretically provide a properly
conﬁgured ternary complex of polymerase, DNA and RNA, primed
for NPHI termination activity (Tate and Gollnick, 2011). The mRNA
capping activity of CE is not required for early gene transcription
termination, however both the D1 and D12 subunits must be
present (Luo et al., 1995; Condit et al., 1996; Yu and Shuman, 1996).
CE is one of three viral factors required for intermediate gene
transcription initiation (Vos et al., 1991b). The other factors are
VITF1, comprised of the E4 core subunit of RNA polymerase, and
VITF3, a heterodimer of the viral A8 and A23 proteins (Rosales
et al., 1994; Sanz and Moss, 1999). A cellular factor consisting of
G3BP and p137 has also been reported to stimulate intermediate
gene transcription in vitro (Katsafanas and Moss, 2004). Formation
of a stable complex between capping enzyme and RNA polymerase
seems to be a prerequisite for intermediate gene transcription,
otherwise little is known about the mechanism of action of
intermediate gene transcription initiation factors (Vos et al.,
1991a). The mRNA capping activity of CE is not required for
intermediate gene transcription initiation, however both the D1
and D12 subunits must be present (Harris et al., 1993; Condit et al.,
1996).
We have described previously a temperature sensitive mutant
in gene D1R, Dts36, the phenotype of which suggests effects on all
three roles of CE: mRNA capping, early gene transcription elon-
gation and intermediate gene transcription initiation (Shatzer
et al., 2008). Speciﬁcally, although mRNA capping was not exam-
ined directly, steady state levels of some early viral mRNAs were
decreased, consistent with a defect in mRNA capping. The mutant
also displayed transcriptional readthrough of early viral genes
consistent with a defect in early gene transcription termination,
and decreased steady state levels of speciﬁc intermediate but not
late gene transcripts, consistent with a defect in intermediate gene
transcription initiation. The mutation comprises a glycine to
aspartic acid substitution on the surface of the MTase domain of
D1, distant from either the catalytic site or the D12 interaction
domain. Our goal in the work presented here was to perform a
biochemical analysis of the Dts36 mutant CE in order to sub-
stantiate the phenotypic analysis and provide additional
mechanistic insight into the multifunctional nature of the enzyme.
We ﬁnd that the mutant enzyme displays defects in both MTase
and GTase activities while the TPase activity and the D12 subunit
interaction are unaffected. The mutant enzyme is also defective in
stimulating early gene transcription termination and intermediate
gene transcription initiation in vitro. The ﬁndings are interpreted
in light of the 3D structure of the enzyme.Results
CE abundance in WT and Dts36 virions; enzyme puriﬁcation
WT and Dts36 virions were puriﬁed from BSC-40 cells grown at
30 °C. The overall protein content in the virion preparations was
examined by SDS-PAGE analysis of varying amounts of WT virions
and Dts36 virions, visualized by Coomassie stain (Fig. 2A). Similar
polypeptide staining patterns were observed between WT virions
Fig. 2. SDS-PAGE and western blot analysis of virion-encapsidated and puriﬁed CE. Varying amounts of puriﬁed IHDW and Dts36 virions were denatured and their poly-
peptides separated by 11% SDS-PAGE. (A) Polypeptides visualized by Coomassie stain. Protein standards in the ﬁrst lane indicate the size of the polypeptides. (B) Western blot
of the CE subunits, D1 and D12. (Top panel) D1 was detected using anti-D1 polyclonal primary antibody followed by anti-rabbit-HRP monoclonal secondary antibody. (Bottom
panel) D12 was probed using anti-D12 polyclonal primary antibody followed by anti-rabbit HRP monoclonal secondary antibody. Molecular weight markers are indicated to
the right of the blot. (C) Recombinant wildtype and Dts36 CE proteins puriﬁed from E. coli analyzed on a 10% SDS-PAGE gel stained with Coomassie blue. Lanes 1 and
3 contain 3 mg of each protein and lanes 2 and 4 contain 6 mg of each protein. Molecular weight markers are indicated to the left of the gel, and the identities of the major
bands are indicated at the right. D1 CT indicates a C-terminal proteolytic fragment of the D1 protein that is consistently observed when CE is expressed in and puriﬁed from
E. coli.
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comparable in protein content and abundance to that of WT vir-
ions. Western blot analysis (Fig. 2B) revealed no signiﬁcant dif-
ference between WT and Dts36 virions in abundance or size of CE
subunits D1 and D12.
WT and Dts36 CE D1 and D12 subunits were co-expressed in
Escherichia coli and afﬁnity puriﬁed by virtue of a histidine tag on
the N-terminus of the D1 subunit as described in Materials and
methods. Following the initial puriﬁcation, the N-terminal tag was
proteolytically removed from the D1 subunit and CE further pur-
iﬁed by gel ﬁltration chromatography. The proteolysis step leaves
the D1 subunit with an unmodiﬁed N-terminus but also produces
a D1 C-terminal fragment that was identiﬁed using antibodies
speciﬁc for the N and C terminus of D1 (data not shown). The
purity of the ﬁnished enzyme preparations was examined by SDS-
PAGE and Coomassie staining (Fig. 2C.)
Dts36 nucleoside triphosphate phosphohydrolase (TPase) activity
As described in Introduction, the CE TPase hydrolyzes the
gamma phosphate from a nascent triphosphorylated mRNA 50
terminus, thus priming the RNA to accept an incoming GMP for
the subsequent GTase reaction (Yu and Shuman, 1996; Myette and
Niles, 1996a). The TPase will also hydrolyze the gamma phosphate
from free nucleotides in vitro, providing a convenient in vitro
assay (Myette and Niles, 1996a).
Dts36 CE TPase activity was measured by examining the
amount of ATP hydrolyzed in the presence of CE using either ATP
or RNA as a substrate. Increasing amounts of either puriﬁed WT or
Dts36 CE were incubated with γ32P-ATP for 15 min at 37 °C.
Reaction products were separated by PEI-cellulose thin layer
chromatography and visualized by autoradiography (Fig. 3A). The
percentage of ATP hydrolyzed was calculated and plotted as a
function of CE concentration (Fig. 3B). Addition of increasing
amounts of either WT or Dts36 CE resulted in a linear increase in
ATP hydrolyzed. No differences in ATPase activity were observed
comparing the WT and mutant enzyme. TPase activity was alsotested using an RNA substrate. A synthetic 25 nt 50 gamma 32P
labeled RNA was incubated with increasing amounts of either WT
or Dts26 CE and liberation of 32Pi was assessed by thin layer
chromatography as described in Materials and methods (Fig. 3D).
The plateau observed in these titrations occurs because at high
concentrations of enzyme the substrate is exhausted. Never-
theless, WT and Dts36 CE both hydrolyzed Pi from RNA with
identical kinetics. These results suggest that the TPase activity of
CE is unaffected by the Dts36 mutation.
To examine whether Dts36 CE TPase activity is thermolabile,
the ATPase assays were repeated using either ATP (Fig. 3C) or RNA
(Fig. 3D) as a substrate, but with CEs that had been pre-incubated
for 15 min at either 0 °C or 37 °C. Hydrolysis was plotted as a
function of enzyme concentration. Pre-incubation at on ice did not
affect either enzyme's ATPase activity. Although both WT and
Dts36 CE showed a slight decrease in activity following pre-
incubation at 37 °C, no signiﬁcant difference in thermolability
was observed comparing the two enzymes. These results suggest
that the Dts36 CE mutation does not affect TPase thermolability.
Dts36 guanylyltransferase (GTase) activity
As outlined in the Introduction, the GTase activity of CE com-
prises two partial reactions (Shuman and Hurwitz, 1981). The ﬁrst
reaction involves hydrolysis of GTP to GMP and formation of a
covalent CE–GMP complex intermediate. CE–GMP complex for-
mation can occur in either the presence or absence of acceptor
RNA. The second reaction involves the transfer of the GMP to the
50-diphosphate terminus of the acceptor mRNA through an
inverted G(50)ppp(50)N linkage. This latter reaction is referred to as
transguanylylation.
GTase activity in Dts36 virions was ﬁrst examined by compar-
ing the formation of the CE–GMP intermediate using permeabi-
lized WT and Dts36 virions. CE–GMP formation was assayed by
incubating increasing amounts of permeabilized virions at 30 °C or
39 °C in the presence of γ32P-GTP. After 15 min of incubation, the
reactions were stopped with SDS-PAGE sample buffer, boiled and
Fig. 3. Dts36 TPase activity. (A) Autoradiogram of ATPase assay of WT and Dts36 CE. (B) The moles of ATP hydrolyzed were determined by determining the fraction of Pi
released from a known input mols of ATP. (C) Analysis of the thermostability of the TPase activity of WT and Dts36 CE. Enzymes were pre-incubated for 15 min either on ice
or at 37 °C after which hydrolysis of ATP was assayed as in (A) and plotted as in (B). (D) TPase activity using an RNA substrate was determined by calculating the amount of Pi
hydrolyzed from 50- [32P] RNA. Pmoles hydrolyzed was plotted versus the amount of CE in the reaction. (E) The thermostability of the TPase activity on an RNA substrate was
analyzed by pre-incubating CE samples on ice or at 37 °C for 15 min and then assaying TPase activity. Activity was calculated and plotted as is (D).
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radioactive band, corresponding to the large subunit of CE
(97 kDa), was observed in the autoradiogram. The intensity of
the band was proportional to the amount of virions in the reaction.
Band intensity at each amount of Dts36 virions was compared to
the band intensity in the corresponding WT reaction, and the
relative fraction of CE–GMP complex formation was calculated
(Fig. 4B). Dts36 virions were approximately 50% as active as WT in
forming CE–GMP complexes at both the permissive (30 °C) and
non-permissive temperatures (39 °C). CE–GMP complex formation
was also determined using puriﬁed recombinant WT and Dts36 CE
(Fig. 4C and D). Similar to the result obtained with permeabilized
virions, CE–GMP complex formation using Dts36 CE was reduced
to approximately 60% of the amount observed with WT CE.
To determine whether CE–GMP complex formation was ther-
molabile, permeabilized virions or puriﬁed CE was pre-incubated
at varying temperatures prior to incubation with γ32P-GTP (Fig. 5).
Using either permeabilized virions or puriﬁed CE, the amount ofDts36 CE–GMP formation decreased relative to WT CE–GMP for-
mation, demonstrating that the Dts36 mutation causes CE–GMP
formation to be thermolabile. It seems likely that the formation of
the CE–GMP complex is sufﬁciently rapid such that the thermol-
ability observed upon preincubation of virions or puriﬁed enzyme
(Fig. 5) is masked if reactions are done at non-permissive tem-
peratures in the absence of preincubation (Fig. 4).
The GTase of Dts36 was next examined for transguanylylation
activity. Unlabeled 50 triphosphorylated RNA was synthesized
in vitro using T7 RNA polymerase. Increasing amounts of WT or
Dts36 CE were incubated with the unlabeled RNA in the presence
of α32P-GTP and GTP at 37 °C for 4 min. Excess GTP was included in
the reactions in an attempt to overcome defects in CE–GMP
complex formation detected previously. RNA was then separated
by denaturing PAGE and imaged by autoradiography (Fig. 6A). The
band observed represents RNA that has had a 32P-GMP transferred
to its 50 terminus. The amount of Dts36 CE transguanylylation
activity was calculated as a fraction of maximum WT CE
Fig. 4. CE:GMP complex formation. (A) Varying amounts of permeabilized IHDWor Dts36 virions were incubated with α32P-GTP at either 30 °C or 39 °C for 15 min. Reactions
were analyzed on a 11% SDS-PAGE followed by autoradiography. (B) The amount of CE:GMP present was calculate by dividing the band intensity by the amount of virions
present in the reaction. Percent CE:GMP was then calculated by normalizing to the amount of CE:GMP present in the corresponding reactions containing IHDW virions.
(C) Varying amounts of puriﬁed WT or Dts36 CE were incubated with α32P-GTP at 30 °C for 15 min and analyzed by SDS PAGE as described in (A). (D) Plot of the amount of
CE–GMP complex formed with WT and Dts36 CE. The amount of CE–GMP complex formed with 0.5 mg WT CE was set at 100%.
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transguanylylation activity was observed between WT CE and
Dts36 CE under these reaction conditions. We then tested WT and
Dts36 CE to determine whether the transguanylylation activity
was thermolabile. WT and Dts36 CE were preincubated for 10 min
on ice or at 37 °C and then assayed for transfer of 32P-GMP to the 50
triphosphorylated RNA substrate as described above (Fig. 6C).
Preincubation of Dts36 CE at 37 °C reduced transguanylylation
activity compared to WT enzyme preincubated at either 37 °C or
on ice, or Dts36 enzyme preincubated on ice, demonstrating that
the Dts36 CE is thermolabile for transguanylylation. Given that CE–
GMP complex formation is also thermolabile, it is difﬁcult to
determine whether the transguanylylation partial reaction is
speciﬁcally thermolibile as well, however in aggregate the results
show that the GTase activity of the Dts36 CE is thermolabile.
Dts36 methyltransferase activity
(N7-) methylation of the 50 guanylate cap on viral mRNA is the
ﬁnal reaction in the cap 0 structure formation. The viral capping
enzyme (CE) methyltransferase (MTase) activity transfers a methyl
group from a S-adenosylmethionine (SAM) donor to an acceptor,
which can be either a 50 guanylate capped mRNA or free GTP with
a Km of 0.21 μM and 33 μM respectively (Martin and Moss, 1976;
Higman et al., 1994).
Dts36 MTase activity was ﬁrst measured in the context of
permeabilized virions using viral transcripts as the methyl
acceptor, such that guanylylated mRNA transcribed in virions
would be transmethylated concurrently with transcription. Viral
transcription was performed by incubation of permeabilized vir-
ions in the presence of α32P-UTP and unlabeled SAM to monitorthe amount of RNA synthesis during the incubations. Transcripts
were quantiﬁed by TCA precipitation and scintillation counting
(Fig. 7A). Transcription from Dts36 virions levels off after 30 min of
incubation at 39 °C, otherwise no signiﬁcant difference in RNA
synthesis was observed between reactions containing WT virions
compared to reactions containing Dts36 virions, nor was a differ-
ence observed between permissive and non-permissive tempera-
tures. Co-transcriptional transmethylation was measured by
incubation of permeabilized virions in the presence of all 4 NTPs
and 3H-SAM at either the permissive (30 °C) or non-permissive
(39 °C) temperatures. Methylated transcripts, which contain a 3H
radiolabeled methyl group, were quantiﬁed by TCA precipitation
and scintillation counting (Fig. 7B). Reactions containing WT vir-
ions contained measurable quantities of methylated transcripts
after 15 min of incubation at either 30 °C or 39 °C, and methylated
transcripts continued to accumulate during the entire 45 min
incubation. Conversely, reactions containing Dts36 virions failed to
accumulate methylated transcripts at either temperature. Given
that transcription was unaffected in Dts36 virions, the absence of
methylated transcripts in reactions containing Dts36 virions is
likely a result of a defect in mRNA capping and not in mRNA
synthesis. However, given that CE–GMP complex formation is at
least partially defective under these conditions and could there-
fore decrease the availability of transguanylylated substrate in
premeabilized virions, we sought to assess MTase independently
of GTase.
Virion MTase activity in permeabilized virions was assayed
independently of GTase using free GTP as the methyl acceptor. The
reaction conditions were the same as for the coupled transcription
MTase assays described above except that CTP, ATP, and UTP were
excluded from the reaction. Following incubation, methylated GTP
Fig. 5. Thermolability of Dts36 CE:GMP complex formation. (A) Permeabilized
IHDW and Dts36 virions were preincubated at 4, 30, or 39 °C for 0, 5, 10, and
15 min. These virions were then incubated with α32P-GTP at 39 °C for 15 min.
Reactions were analyzed on an 11% SDS-PAGE followed by autoradiography. The
amount of CE:GMP present was calculated by dividing the band intensity by the
amount of virions present in the reaction. Percent CE:GMP was then calculated by
normalizing to the amount of CE:GMP present in the corresponding reactions
containing IHDW virions. (B) Thermolability of GMP complex formation with
puriﬁed WT and Dts36 CE. Puriﬁed WT or Dts36 CE was pre-incubated at either 5 °C
or 37 °C for 15 min and then mixes with α32P-GTP and incubated at 30 °C for
15 min. The reactions were analyzed by SDS-PAGE as described in (A). (C) Plot of
GMP complex formation from (B). The amount of complex formed with 2.0 mg WT
CE pre-incubated at 5 °C was set at 1.00 and the other samples normalized to
this value.
Fig. 6. Dts36 guanyltransferase activity. (A) Puriﬁed T7 synthesized RNA was
incubated with α32P-GTP and either WT or Dts36 CE (20, 50, and 60 ng) at 37 °C for
4 min. Samples were analyzed by denaturing PAGE and visualized by auto-
radiography. The marker lane (M) contains the same RNA used as substrate,
however uniformly labeled during synthesis. (B) Plot of guanyltransferase activity
from several assays as shown in (A). The activity obtained with 100 ng WT CE was
set at 1.00 and the other samples normalized to this value. Values shown are the
average of three independent assays each done in duplicate with error bars
representing standard deviations. (C) Guanylyltransferase was assayed after pre-
incubation of either WT or Dts36 CE for 10 min on ice or at 37 °C. Reactions were
analyzed and quantiﬁed as in (A) and (B).
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tion counting (Fig. 7C). The results show that Dts36 virions are
inactive for MTase activity at both 30 °C and 39 °C, unlike WT
virions, which showed MTase activity at both temperatures.
MTase activity of puriﬁed CE was assessed using an authentic
RNA substrate. Unlabeled RNA was synthesized in vitro using T7
RNA polymerase and then transguanylylated using CE in the pre-
sence of α32P-GTP to yield radiolabeled, guanylylated, unmethy-
lated substrates (G32pppNpNp….) for the transmethylation reac-
tion. Varying amounts of puriﬁed CE were incubated with the
radiolabeled guanylylated RNA at 37 °C for 15 min in the presence
or absence of SAM. Following incubation, the RNA was treated
with P1 nuclease to cleave the 50 cap from the RNA and the clea-
vage products were separated by PEI-cellulose thin layer chro-
matography (Fig. 8A). The percentage of transcripts methylated by
either WT CE or Dts36 CE was calculated and plotted as a function
of enzyme concentration (Fig. 8B). In the absence of SAM, addition
of either WT or Dts36 CE had no effect on the guanylylated cap
(compare Fig. 8A, lanes 3–4 and lane 2). Addition of 13 ng of WT
CE and SAM resulted in 60% of the guanylated caps being
methylated (Fig. 8A, lane 5 and Fig. 8B) and MTase activity pla-
teaued at 80% with addition of 65 ng WT CE (Fig. 8A, lane 7 and
Fig. 3B). Addition of Dts36 CE and SAM also resulted in methylated
transcripts (Fig. 8A, lanes 9–12), however the Dts36 MTase activity
plateaued at 40%, half that of WT CE (Fig. 8B). Unlike previousMTase experiments using permeabilized virions (Fig. 7), these
results suggest that Dts36 CE MTase activity is impaired but still
active.
The apparent discrepancy in MTase activity observed between
virion and puriﬁed CE could theoretically be attributed to either
the different methyl acceptors employed or the different CE
sources. To ensure that puriﬁed recombinant Dts36 CE behaves in
a similar fashion as the Dts36 CE packaged within the virions, the
previous MTase assay, which used 3H-SAM as the methyl donor
and free GTP as the methyl acceptor (Fig. 8C), was repeated with
puriﬁed CE. In the presence of WT CE, signiﬁcant levels of
methylated GTP accumulated during the 45 min incubation at both
30 °C and 39 °C. However, Dts36 CE failed to methylate GTP at
either temperature. These results are consistent with the data
obtained using permeabilized virions as the CE source, demon-
strating that Dts36 CE MTase activity is comparable using per-
meabilized virions or puriﬁed enzyme. Therefore, the Dts36 MTase
activity observed in Fig. 8 is likely attributable to the different
methyl acceptors used. CE has a higher afﬁnity for guanylylated
Fig. 7. Methyltransferase activity in IHDW and Dts36 virions. (A) Transcription.
Transcription was stimulated in permeabilized IHDW or Dts36 virions by the
addition of all four nucleotides in the presence of α32P-UTP and SAM and incuba-
tion at either 30 or 39 °C. A various times samples were TCA precipitated and
quantiﬁed by scintillation counting. (B) Transcript methylation. Transcription was
stimulated in permeabilized IHDW or Dts36 virions by the addition of all four
nucleotides in the presence 3H-SAM and incubation at either 30 or 39 °C. A various
times samples were TCA precipitated and quantiﬁed by scintillation counting.
(C) GTP methylation. Permeabilized IHDW or Dts36 virions were incubated with
GTP and 3H-SAM at either 31 or 39 °C. A various times samples were spotted on
DEAE-cellulose ﬁlters, washed to remove unincorporated 3H-SAM and quantiﬁed
by scintillation counting.
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saturating SAM concentrations. The lower afﬁnity for GTP
methylation may be exacerbating the defect in Dts36 CE MTase
activity. Furthermore, the lack of measureable MTase activity in
Dts36 virions when viral transcripts were used as the methyl
acceptor (Fig. 7A) may be due to a defect in an upstream capping
reaction such as guanylyltransferase, which is bypassed when
guanylylated transcripts are synthesized in vitro (Fig. 8).
To assess whether the Dts36 CE MTase activity observed in
Fig. 8 is thermolabile, WT CE and Dts36 CE were pre-incubated for
15 min at either 5 °C or 37 °C and then assayed for MTase using
guanylylated RNA as a substrate (Fig. 9). In the absence of SAM,
WT CE and Dts36 CE failed to methylate the guanylated RNAs
(Fig. 9A, compare lanes 2 and 3–4). When WT CE or Dts36 CE werepre-incubated at 4 °C, methylated caps were observed (Fig. 9A,
lanes 5–8 and lanes 9–12 respectively) and the percentage of
methylated caps was similar to previous measurements (compare
Figs. 8 and 9). Pre-incubation of Dts36 CE at 37 °C caused a larger
percentage decrease its MTase activity compared to the WT
enzyme, suggesting that the Dts36 CE MTase activity is slightly
thermosensitive.
Dts36 early gene transcription termination
In addition to generating the 50 cap 0 structure on viral mRNA,
vaccinia CE also functions as an early gene transcription termina-
tion factor (Shuman et al., 1987; Luo et al., 1991). Prior data suggest
that the role of CE in transcription termination is to recognize the
termination signal, U5NU, located in the nascent transcript
(Christen et al., 2008). In vivo studies of Dts36 revealed that early
transcripts were abnormally long and had increased heterogeneity
in their 30 termini, suggesting a defect in early gene transcription
termination (Shatzer et al., 2008). To conﬁrm this hypothesis,
in vitro early transcription termination assays were performed
using puriﬁed Dts36 CE.
Transcription termination assays were carried out using an
artiﬁcial early gene template, Ter29, attached to paramagnetic
beads. The Ter29 template contains a strong synthetic vaccinia
early promoter driving transcription through a 20 bp G-less cas-
sette followed by a 169 bp of nonspeciﬁc DNA (Fig. 10A). The T5NT
sequence, which acts as the transcription termination signal when
transcribed into U5NU, is located 8 bp downstream of the G-less
cassette. When U5NU is extruded from the transcription elonga-
tion complex, CE recognizes the termination signal and stimulates
transcription termination to occur 75 nt downstream from the
start of transcription. In the absence of CE, the transcription
elongation complex does not terminate in a signal-dependent
manner but rather transcribes to the end of the DNA template to
produce a 189 nt read-through (RT) transcript.
Transcription was initiated by the addition of virion extract,
ATP, CTP, α32P-UTP, and 30O-Methyl-GTP to bead-bound Ter29
template and incubation for 15 min at 30 °C. Under these reaction
conditions, radiolabeled 21 nt transcripts were synthesized and
the ternary elongation complex was halted at G21. Elongation
complexes were washed with reaction buffer to remove unin-
corporated nucleotides and endogenous CE. After washing, all four
NTPs and either WT or Dts36 CE were added to the reactions and
transcription continued past G21. Resulting transcripts were
separated on a denaturing polyacrylamide gel, visualized by
autoradiography and the autoradiograms quantiﬁed (Fig. 10B and
C). Two major bands were observed. The uppermost doublet
represents full length (189 nt) RT transcripts, and the lower
band represents terminated transcripts (Term) (75 nt). In the
absence of exogenous CE, the majority of radiolabeled products
were RT transcripts, with only 10% of the products being ter-
minated transcripts. As increasing amounts of WT CE were added
to the reactions, the percentage of terminated transcripts (Term)
increased from 10% to 80%. When increasing amounts Dts36
CE were added to the reactions, the percentage of terminated
transcripts only increased from 10% to 30%, demonstrating a
defect in the ability of Dts36 CE to stimulate early gene tran-
scription termination.
Dts36 intermediate gene transcription initiation
Vaccinia capping enzyme is also required for initiation of
intermediate gene transcription, along with the Vaccinia Inter-
mediate Transcription Factor 3 (VITF-3) (Vos et al., 1991b; Sanz and
Moss, 1999). The role of either protein in transcription initiation
remains unclear. Phenotypic studies of Dts36 virus demonstrated
Fig. 8. Methyltransferase activity of puriﬁed Dts36 CE. (A) Puriﬁed T7 synthesized RNA was guanylylated using α32P-GTP and WT CE and incubated with increasing amounts
of either WT or Dts36 CE and in the presence or absence of SAM at 37 °C for 15 min. The 50 caps were cleaved off the RNA with P1 nuclease. Products were resolved by PEI
cellulose TLC and visualized by autoradiography. (B) Percent methylation was calculated as the amount of m7GpppG divided by the sum of m7GpppG and GpppG, and plotted
versus the amount of CE present in the reaction. (C) GTP methylation. Puriﬁed WT or Dts36 CE was incubated with GTP and 3H-SAM at either 30 or 39 °C. A various times
samples were captured on DEAE-cellulose ﬁlters and the amount of 3H-labeled GTP was measured by scintillation counting. The amount of 3H incorporation is plotted as a
function of time.
Fig. 9. Thermolability of methyltransferase activity of puriﬁed Dts36 CE. (A) Puriﬁed T7 synthesized RNA was guanylylated using α32P-GTP and WT CE. These guanylated
transcripts were incubated with increasing amounts of either WT or Dts36 CE preincubated at either 4 or 37 °C, and in the presence or absence of SAM at 37 °C for 15 min.
The 50 caps were cleaved from RNA with P1 nuclease and products were resolved by PEI cellulose TLC and visualized by autoradiography. (B) Percent methylation was
calculated as the amount of m7GpppG divided by the sum of m7GpppG and GpppG, and plotted against the amount of CE present in the reaction.
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Fig. 10. Dts36 activity in in vitro transcription termination and initiation. (A) Diagram of the transcription templates Ter29 and pG8G. Ter29 contains an early gene promoter
(PE) followed by a 20 bp G-less cassette and 169 bp of random sequence. Readthrough transcripts (RT) proceed to the end of the template to yield 189 nt transcript. The
termination signal, T5NT, is located 9 bp downstream of the G-less cassette and stimulates termination to occur 55 bp downstream of the G-less cassette to yield a 75 nt
terminated transcript (Term). Template pG8 contains an intermediate gene promoter (PI) followed by 380 bp G-less cassette (RT). B) Early transcription termination. Ter29
templates were incubated with ATP, CTP, α32P-UTP, 30O-Methyl GTP, and virion extracts at 30 °C for 15 min, which results in transcription elongation complexes stalled at G21
(leftmost lane). Stalled complexes were washed to remove endogenous CE and nucleotides. All four nucleotides and increasing amounts of either WT or Dts36 CE were added
to the reactions, and transcription was allowed to proceed past G21 by incubating at 30 °C for 15 min. Reactions were analyzed by denaturing PAGE and autoradiographed.
Two predominant groups of transcripts, RT and Term, are observed. (C) Percent termination was calculated by dividing the amount of Term transcripts by the sum of RT and
Term transcripts. Percent termination was then plotted against the amount of CE. (D) Intermediate transcription initiation. pG8 templates were incubated with ATP, GTP, CTP,
α32P-UTP, puriﬁed His-A24 RNA Polymerase, VITF-3 and increasing amounts of either WT or Dts36 CE at 30 °C for 30 min. Reactions were analyzed by denaturing PAGE and
autoradiographed. The arrow indicates the expected 350 nt transcription product.
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tion at non-permissive temperatures with this virus, suggesting
the G705D mutation in Dts36 CE compromises its role in inter-
mediate transcription initiation (Shatzer et al., 2008). To test this
hypothesis, in vitro intermediate transcription assays were
examined for RNA synthesis in the presence of either WT or Dts36
CE. A linearized plasmid (pG8G) containing the vaccinia inter-
mediate gene G8R promoter followed by a 380 bp G-less cas-
sette was used as an artiﬁcial intermediate gene template in these
assays. Reaction mixtures contained the pG8G template, CTP, ATP,
UTP, and α32P-UTP. Puriﬁed vaccinia RNA polymerase, VITF-3, and
either WT or Dts36 CE were added to the reaction mixtures and
incubated at 30 °C for 15 min. Transcripts were isolated by dena-
turing PAGE and visualized by autoradiography (Fig. 10D). At all
concentrations of WT CE, the reactions resulted in the expected
350 nt transcript. Conversely, the 350 nt transcript was not
observed in reactions containing Dts36 CE, regardless of the con-
centration used, nor were shorter transcripts observed. These
results show that the Dts36 mutant capping enzyme is defective in
stimulating intermediate gene transcription, presumably via a
defect in its previously described activity in transcription
initiation.
Dts36 subunit association
D1 TPase and GTase activity can be observed in the absence of
the D12 subunit, however the D1-D12 subunit interaction is
required for full MTase activity of CE (Higman et al., 1994; Mao and
Shuman, 1994). In addition, both subunits must be present inorder for CE to function as a viral early gene transcription termi-
nation factor or a viral intermediate gene transcription initiation
factor (Condit et al., 1996). Since Dts36 CE is impaired in MTase,
early gene transcription termination and intermediate gene tran-
scription initiation, one unifying hypothesis to these defects is that
the G705 mutation disrupts or weakens the D1-D12 association.
We therefore tested for D1-D12 subunit interaction in the Dts36
mutant capping enzyme using co-immunoprecipitation of afﬁnity
tagged D1 and D12 proteins synthesized in vitro in a reticulocyte
lysate and observed no defect in D1-D12 subunit association in the
mutant enzyme compared to WT (data not shown). Importantly,
puriﬁcation of WT and Dts36 CE overexpressed in E. coli repro-
ducibly yielded enzymes with comparable ratios of D1 to D12
subunits (Fig. 2C). We conclude that the G705D mutation does not
signiﬁcantly affect CE subunit dimerization.Discussion
All of the original studies elucidating the activities of the vac-
cinia virus capping enzyme (CE) were purely biochemical in nat-
ure. The enzyme was originally puriﬁed from vaccinia virions
based on its ability to cap a nascent RNA transcript in vitro (Shu-
man et al., 1980). Numerous subsequent biochemical studies
deﬁned the three enzymatic domains of the large D1 subunit of
the CE heterodimer, TPase, GTase and MTase, and delineated the
MTase stimulatory role of the small D12 subunit (see Introduction
for references). These studies culminate in the recent elegant
atomic structure of the enzyme, clearly demonstrating the
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domains, and the association of the D12 subunit with the MTase
domain (Kyrieleis et al., 2014). In parallel with characterization of
the mRNA capping activities of CE, puriﬁcation from virions of an
activity required for early viral gene transcription termination
in vitro yielded CE as the viral termination factor (VTF) (Shuman
et al., 1987). Remarkably, puriﬁcation from infected cells of an
activity required for initiation in viral intermediate gene tran-
scription in vitro once again yielded CE (Vos et al., 1991b). While in
aggregate these studies suggested that CE functions not only to
cap viral mRNA but also to terminate early gene transcription and
initiate intermediate gene transcription, evidence for the multi-
functional role of CE in vivo was lacking until the phenotypic
characterization of Dts36, a vaccinia virus temperature sensitive
mutant bearing a missense mutation in the D1 subunit of CE
(Shatzer et al., 2008). The phenotype of this mutant was consistent
with CE playing a role in mRNA capping, early gene transcription
termination and intermediate gene transcription initiation, how-
ever some of the evidence was of necessity circumstantial. Under
non-permissive conditions, the mutant clearly produced 30
extended early mRNAs consistent with a defect in early gene
transcription termination. Some early mRNAs were decreased in
abundance, consistent with a defect in mRNA capping, however
cap formation in vivo was not assessed directly. Steady state levels
of intermediate gene transcripts were selectively reduced relative
to late gene transcripts, however a speciﬁc defect in intermediate
gene transcription initiation was not demonstrated. With the
biochemical characterization of CE encoded by Dts36 presented
here, the circle is closed. We report that the Dts36 CE is defective
in both GTase and MTase but not TPase in vitro, consistent with an
mRNA capping defect in vivo, and we report that the Dts36 CE is
defective in viral early gene transcription termination and viral
intermediate gene initiation in vitro, consistent with defects in
these same processes in vivo. We can now state with conﬁdence
that the vaccinia CE does indeed play a role in all three processes
during virus infection.
Based on the nature of the mutation in Dts36 and the speciﬁcs
of the defects in mRNA capping described, we can speculate on the
mechanism of temperature sensitivity in the mutant enzyme. The
mutation comprises a change from glycine to aspartic acid at
position 705 in the methyltransferase domain of the D1 subunit of
CE. G705 is conserved in all poxviruses and cellular cap methyl-
transferases as well as Shope fribroma virus and African swine
fever virus (Mao and Shuman, 1994; Schwer and Shuman, 2006).
G705 is on the surface of the enzyme, comprising part of beta
strand 5 (701–712) which is a well conserved feature of an ordered
seven stranded beta-sheet characteristic of class I methyl-
transferases (de la Pena et al., 2007). Importantly, in the 3D
structure of CE, G705 is signiﬁcantly removed from both the MTase
active site (represented by the SAH binding site in Fig. 1) and is
also distant from the D1/D12 interaction surface. The G705D
mutation does not measurably affect the D1/D12 subunit interac-
tion or the activity of the TPase, however both MTase and GTase
activity are compromised. The magnitude of the defect in MTase
and GTase depends somewhat on the assay used for activity.
Thermolability of both activities can be demonstrated, consistent
with the temperature sensitive character of the mutant virus
in vivo. The simplest mechanistic explanation for the effects of the
G705D mutation is that it causes a conformational change in the
MTase domain that propagated laterally into the GTase domain
and exacerbated by elevated temperature, thus compromising
both MTase and GTase activities while leaving TPase activity and
D1/D12 subunit interaction unaffected.
The effects of the G705D mutation on capping provide some
insight into the mechanism of action of CE in early viral gene tran-
scription termination and intermediate viral gene transcriptioninitiation. Previous studies demonstrate that mRNA capping is not
required for CE activity in early viral gene transcription termination
and intermediate viral gene transcription initiation, however both the
D1 and D12 subunits must be present (Harris et al., 1993; Luo et al.,
1995; Yu and Shuman, 1996; Condit et al., 1996). As described in the
Introduction, during early viral gene transcription termination CE is
responsible for recognition of the U5NU termination sequence via an
apparent interaction with the TPase domain (Christen et al., 2008).
Our results show that the TPase activity of Dts36 CE is intact, implying
that the TPase domain of the Dts36 CE is unaltered, suggesting that
the sequence recognition activity of CE in early termination may be
unimpaired. Given that the conformation of the MTase and GTase
domains are altered, we speculate that the mechanism by which CE
effects early gene transcription termination must involve an interac-
tion between the MTase and/or GTase domains and another factor
involved in termination, namely RNA polymerase, H4 or NPHI. CE
interaction with RNA polymerase has been demonstrated in two
laboratories (Broyles and Moss, 1987; Hagler and Shuman, 1992). As
noted in the Introduction, the mechanism by which CE stimulates
intermediate gene transcription initiation apparently involves for-
mation of a complex between CE and RNA polymerase (Vos et al.,
1991a). Our results suggest that this interaction may involve the
MTase and/or GTase domains of CE. Given that the two transcription
reactions, early gene termination and intermediate gene initiation,
have only CE and RNA polymerase in common, it is amusing to
speculate that the two reactions have in common the same interac-
tion between RNA polymerase and the MTase and or GTase domains
of CE. Hopefully, future studies will provide a detailed mechanistic
picture of the role of CE in transcription.Materials and methods
Virion puriﬁcation and virion extract preparation
Wild type vaccinia virus strain IHDW and the temperature sensi-
tive mutant Dts36 have been described previously (Shatzer et al.,
2008). For puriﬁcation, virus was grown on BSC-40 cells at 30 °C (the
permissive temperature for Dts36) as described (Shatzer et al., 2008).
Virus was puriﬁed from cytoplasmic extracts of infected cells by
centrifugation through a sucrose cushion followed by banding on
potassium tartrate equilibrium density gradients as previously
described (Moussatche and Keller, 1991). The puriﬁed virions were
quantiﬁed by optical density at 260 nm (1 OD260¼64 μg virus).
Extracts for early gene transcription reactions were prepared from
puriﬁed virions as described previously (Tate and Gollnick, 2011).
Construction of vA24his
Vaccinia virus gene A24R encodes the second largest subunit of
the viral RNA polymerase.
A recombinant vaccinia virus, vA24his, was constructed con-
taining a 10 histidine tag fused to the C terminus of gene A24R,
followed by GFP expressed from a synthetic vaccinia early/late
promoter to facilitate screening for recombinant virus. In WT WR,
a fragmented copy of the non-essential A-type inclusion (ATI) gene
lies immediately downstream of A24R in the opposite orientation
relative to A24R. A PCR fragment designed for insertion of the
desired sequences was constructed from three precursor PCR
fragments. Fragment 1 (531 bp) containing the C terminal 0.5 kb of
gene A24R with the 10 his sequence fused to the C terminus of
A24R was ampliﬁed from genomic vaccinia virus strain WR DNA
using a downstream primer that included the added synthetic
10 his sequence. Fragment 2 (935 bp) containing GFP driven by
a synthetic early/late vaccinia virus promoter was ampliﬁed from
the plasmid pSC65-gfp-PCT (a gift of Dr. Peter Turner, University of
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overlap fragment 1, and a downstream primer containing
sequences from the vaccinia virus ATI gene. Fragment 3 (545 bp)
containing the C terminal 0.5 kb of the ATI gene was ampliﬁed
from genomic vaccinia virus strain WR DNA using an upstream
primer containing both GFP and ATI sequences designed to overlap
the downstream end of fragment 2. The three fragments were
mixed and ampliﬁed using the outermost primer pair to yield a
single fragment of 1920 bp. This fragment was transfected into WT
vaccinia virus strain WR infected BSC40 cells, and lysates from the
infected, transfected cells were screened for formation of green
ﬂuorescent plaques. Virus from green plaques was repeatedly
plaque puriﬁed, grown and the relevant region was sequenced to
conﬁrm the accuracy of the construction.
Cloning genes for recombinant vaccinia proteins
Capping Enzyme (CE) was puriﬁed from E. coli BL21(DE3)
transformed with pET26Smt3D1R-D12L. This plasmid contains the
vaccinia D1R and D12L genes, which encode the large and small
subunits respectively of CE. The D1 coding segment is in-frame
with the yeast SUMO protein Smt3, which contains 10 His codons
at the N-terminus and is expressed from a T7 promoter in the
plasmid. The D12L gene is expressed from its own T7 promoter.
To create pET26Smt3D1R/D12L, the D1R coding segment was
ampliﬁed by PCR from Pet3D1R-63 (generously provided by Dr.
Edward Niles). The primers used incorporated BglII and HindII
sites into the 50 and 3 ends of the gene respectively. The resulting
dsDNA fragment was digested with BglII and HindIII and ligated
into pET26Smt3 digested with BamHI and HindIII. This ligation
results in D1 being in frame with Smt3 following the Gly-Gly motif
near the C-terminus of the coding segment (generous gift from Dr.
Kiong Ho). The resulting plasmid was named pET26Smt3-D1R.
The D12L gene was ampliﬁed from pET3aD12L-8 (Generous gift
from Dr. Edward Niles). The upstream primer was complementary
to the plasmid upstream of the T7 promoter and incorporated a
NotI site upstream of the promoter. The downstream primer
bound to the 30 end of the D12L gene and incorporated an XhoI site
following the stop codon. The resulting PCR fragment was digested
with NotI and XhoI and ligated into similarly digested pET26Smt3-
D1R yielding plasmid pET26Smt3D1R/D12L.
To create pET26Smt3D1R(G705D)/D12L, the G705D mutation in
the D1R sequence was incorporated into pET26Smt3D1R/D12L
using the QuikChange site directed mutagenesis kit (Stratagene).
The Dts36 mutation in pET26Smt3D1R(G705D)/D12L is in a
D1R sequence derived from a WR virus strain background, while
the Dts36 mutation exists originally in an IHDW virus strain
background. The D1R sequence from IHDW possesses three coding
polymorphisms relative to the WR D1R sequence: V5I, T202K, and
R812K (Shatzer et al., 2008). To control for potential effects of
these polymorphisms, the D1R sequence of pET26Smt3D1R
(G705D)/D12L was altered to match the IHDW Dts36 sequence by
incorporating the V5I, T202K and R812K sequence changes using
the QuikChange site directed mutagenesis kit (Stratagene). This
IHDW Dts36 CE was puriﬁed as described below and compared to
WR Dts36 enzyme in early gene transcription termination, ATPase,
GMP binding, and methyltransferase assays. In all assays the IHDW
Dts36 enzyme had the same levels of activity as the WR Dts36
enzyme.
Puriﬁcation of recombinant vaccinia proteins
WT and Dts36 CE
Six liters of BL21(DE3) cells transformed with either pET26Smt3-
D1R/D12L or pET26Smt3-D1R(G705D)/D12L were grown in LB med-
ium supplemented with 50 mg/ml of kanamycin at 37 °C to an A600 of0.6. Cells were chilled on ice for 30 min and ethanol was added to
ﬁnal concentration of 1%. Cells were harvested after additional 18 h at
18 °C and resuspended in 40 ml of Lysis Buffer (25 mM Tris–HCl (pH
8), 1 mM EDTA,10% glycerol, 10 mM β-mercaptoethanol, 50 mMNaCl,
10 mM MgCl2, 0.1% SDS, 0.01% Nonidet P-40, 10 mg/ml aprotinin, and
1mM PMSF). Following 2 passages through a French Press, the cell
lysates were clariﬁed by centrifugation at 30,000 g for 20 min.
Cleared lysates were incubated with Ni-agarose beads at 4 °C for 1 h.
Beads were washed with Binding Buffer (20 mM Tris–HCl (pH 7.9),
0.5 M NaCl, 100 mM EDTA), followed by Wash Buffer (20 mM Tris–
HCl (pH 7.9), 0.5 M NaCl, 60 mM Imidazole (pH 8)). Smt3-D1/D12 was
eluted from the Ni-Agarose beads with Elution Buffer (20 mM Tris–
HCl pH 7.9, 0.5 M NaCl, 1 M Imidazole pH 8). The eluted Smt3-D1/D12
was treated with 1:50 M ratio of ULP1 enzyme to cleave off the Smt3-
His tag from D1. The cleavage reactionwas concurrent with dialysis in
Buffer A (25 mM Tris–HCl (pH 8), 1 mM EDTA, 10% glycerol, 10 mM β-
mercaptoethanol, 50 mM NaCl) overnight at 4 °C. ULP1-cleaved Smt3
was separated from D1/D12 using S-200 size exclusion chromato-
graphy. Protein concentrations were determined using the Pierce BCA
protein assay with BSA as standard.
VITF-3
The plasmid encoding a recombinant VITF-3, pHisA8R-A23R,
was a generous gift from Dr. Bernard Moss. VITF-3 was puriﬁed
from 5 L of BL2(DE3) cells transform with the above plasmid and
was prepared as described (Sanz and Moss, 1999).
A24his viral RNA polymerase
Six liter batches of HeLa S3 cells in suspension were infected
with vA24his at moi¼5 for 18 h at 37°, and washed cell pellets
were stored at 80 °C as previously described (Kay et al., 2013).
All puriﬁcation procedures were performed at 4 °C. Cytoplasmic
extracts were prepared as follows. Pellets were thawed and resu-
supended in 2 packed cell volumes of low salt buffer (25 mM Tris–
HCl, pH 8.0, 5 mM MgCl2, 10 mM NaCl, 2 mM DTT and protease
inhibitor cocktail (Sigma)), incubated 10 min and Dounce homo-
genized 30–50x. Homogenates were centrifuged at 3200 g for
30 min. Supernatants were decanted and saved and the pellets
resuspended in 1 packed cell volume low salt buffer and cen-
trifuged 3200 g for 15 min. The supernatants were combined
and adjusted to 50 mM NaCl and 10% glycerol. Extracts were
centrifuged at 100,000 g for 2 h and the supernatnant decanted,
adjusted to 0.5% NP40, ﬂash frozen and stored at 80 °C. Protein
puriﬁcation was done on extracts prepared from 18 L of infected
cells. Extracts from 36 L cytoplasmic extract preparations were
thawed, pooled, adjusted to 20 mM imidazole and ﬁltered through
a 0.45 μM ﬁlter. Extract was applied to a 5 ml HisTrap column (GE
Healthcare) pre-equilibrated according to the manufacturer’s
instructions. The column was washed with 20 column volumes of
Buffer A (25 mM Tris–HCl, pH 8.0, 10% glycerol, 2 mM DTT and
protease inhibitor cocktail (Sigma)) containing 1 M NaCl and
20 mM imidazole. The column was then washed with 20 column
volumes buffer A containing 1 M NaCl and 60 mM imidazole, fol-
lowed by 20 column volumes of buffer A containing 100 mM NaCl
and 60 mM imidazole. Bound polymerase was eluted in 1 ml
fractions with 20 column volumes buffer A containing 100 mM
NaCl and 250 mM imidazole. Fractions representing a peak of
absorbance at OD280 were pooled and dialyzed into 25 mM HEPES,
pH 7.4 (titrated with KOH), 100 mM KOAc, 1 mM DTT, 15% glycerol
and ﬂash frozen in small aliquots at 80 °C. Analysis of the afﬁnity
puriﬁed RNA polymerase by SDS-PAGE and Coomassie staining
and by western blotting shows that the preparation is still impure
but does not contain detectable amounts of intermediate gene
transcription initiation factors, including CE (data not shown).
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Virion proteins were separated by SDS-PAGE followed by protein
transfer to a nitrocellulose membrane, as described (Towbin et al.,
1979). Polyclonal antibodies against D1 and D12 were generously
provided by Dr. Edward Niles and used at a 1:2000 dilution. The
primary antibodies were detected using polyclonal anti-rabbit con-
jugated to horseradish peroxidase (Santa Cruz Biotechnology) at a
1:10,000 dilution. The secondary antibodies were visualized using
Amersham ECL Western Blot Detection kit as per manufacturer’s
instructions.TPase assay
ATP substrate
TPase assays with puriﬁed WT or Dts36 CE were carried out at
37 °C for 15 min in 10 mL reactions containing 50 mM Tris–HCl pH
8.0, 2 mM DTT, 10 mM MgCl2, 2 mM ATP, and 16.6 nM γ32P –ATP
(3000 Ci/mmol, Perkin Elmer). 2 mL of each reaction was spotted
on a PEI-Cellulose TLC plate, which was developed with 0.5 M LiCl
and 1 M formic acid (Myette and Niles, 1996b). Plates were dried
and reaction products were quantiﬁed using a phosphoimager.
RNA substrate
RNA consisting of 5 repeats of the sequence GAGUU (GAGUU-5)
was used as a substrate for RNA triphosphatase assays. γ-32P-
labeled GAGUU-5 was synthesized as previously described (Myette
and Niles, 1996a, b). Transcription reactions containing 400 μg of
linearized plasmid DNA, 1 mM ATP, CTP, and UTP, 0.5 mM GTP,
0.25 mCi of [γ-32P]GTP (6000 Ci/mmol) and 500 units of T7 RNA
polymerase per 1 ml of reaction were incubated 2 h at 37 °C. The
RNA products were gel puriﬁed from an 8% acrylamide, 8 M urea
gel. Assays contained 2 mMMgCl2 and 3 μM γ-32P -labeled RNA in
a 10-μL reaction volume. Reactions were incubated for 2 min at
37 °C and 2 μL were spotted onto PEI-cellulose TLC plates. Plates
were developed in 0.75 M KH2PO4, pH 3.4. Reaction products
were quantiﬁed using a phosphoimager.CE–GMP complex formation
CE–GMP complex formation in the context of permeabilized
virions was assayed by incubating varying amounts of puriﬁed WT
or Dts36 virions in 16 μL reaction mixtures containing 50 mM
Tris–HCl (pH 8.2), 10 mM DTT, 0.05% Nonidet P-40, 5 mM MgCl2
and 1 μCi α32P-GTP (3000 Ci/mmol, Perkin Elmer). Reactions were
incubated either at 30 °C or 39 °C for 15 min. Products were ana-
lyzed by SDS-PAGE and visualized by autoradiography (Shuman
and Moss, 1990). Thermolability of CE–GMP formation in per-
meabilized virions was analyzed in a similar fashion except virions
were pre-incubated at 4 °C or 39 °C for various lengths of time in
reaction buffer lacking GTP. Following pre-incubation, GTP and
α32P-GTP were added to the reactions and reactions were incu-
bated at 39 °C for 10 min.
CE–GMP complex formation using puriﬁed CE was assayed by
titrating puriﬁed WT or Dts36 CE in 15 μL reaction mixtures con-
taining 50 mM Tris–HCl (pH 8), 2 mM DTT, 10 mM MgCl2, 100 μM
unlabeled GTP and 3 μCi α32P-GTP (3000 Ci/mmol, Perkin Elmer).
Reactions were incubated at 30 °C or 37 °C for 15 min, analyzed by
SDS-PAGE, and visualized by autoradiography (Shuman and Moss,
1990). Thermolability of CE–GMP formation by puriﬁed CE was
analyzed as above except WT or Dts36 CE was pre-incubated at
4 °C or 37 °C for 15 min.Transguanylylation assays
RNA, (GAGUU)11, was synthesized using T7 polymerase. Tran-
scripts were isolated by PAGE, eluted, and quantiﬁed. WT or Dts36
CE was incubated in reaction mixtures containing 50 mM Tris–HCl
(pH 8), 5 mM DTT, 2 mM MgCl2, 1 mM GTP, 5.5 μM 55-mer RNA,
33 nM α32P-GTP (3000 Ci/mmol, Perkin Elmer) in a ﬁnal volume of
15 μL. Reactions were incubated at 37 °C for 4 min. Samples were
analyzed by denaturing PAGE and visualized by autoradiography.Methyltransferase assays
Viral transcripts as methyl acceptor
Methyltransferase activity in permeabilized virions was asses-
sed by measuring the transfer of 3H-labeled S-adenosylmethionine
(SAM) methyl group to viral transcripts synthesized and guanyly-
lated within the virions as described (Gershowitz and Moss, 1979).
2.7 μg of puriﬁed virions were incubated in 100 μL reactions
containing 0.1 M Tris–HCl (pH 8), 10 mM DTT, 10 mM MgCl2, 0.05%
Nonidet P-40, 5 mM ATP, 1 mM CTP, 1 mM GTP, 1 mM UTP, and
3.7 μCi 3H-SAM (18 Ci/mmol, Perkin Elmer) at 30 °C or 39 °C. At
various times, 20 μL samples were removed into 1 ml of 5% tri-
chloroacetic acid (TCA). Precipitated RNA was collected on glass
microﬁber ﬁlters (Whatman) and unincorporated radioactivity
was removed by washing with 5% TCA. Filters were analyzed by
liquid scintillation counting. Concurrent transcription reactions
contained 2.7 μg of puriﬁed virions in 100 uL of 0.1 M Tris–HCl (pH
8), 10 mM DTT, 10 mM MgCl2, 0.05% Nonidet P-40, 5 mM ATP,
1 mM CTP, 1 mM GTP, 0.20 mM UTP and 12.5 μCi α32P-UTP
(3000 Ci/mmol, Perkin Elmer). Transcription reactions were incu-
bated at either 30 °C or 39 °C. At various times, 20 μL samples
were analyzed by TCA precipitation as described above.
GTP as methyl acceptor
Methyltransferase activity in permeabilized virions using GTP
as a methyl acceptor (Shuman and Moss, 1990) was measured by
incubating 2.7 μg of puriﬁed virions in 100 μL of 50 mM Tris–HCl
(pH 8), 10 mM DTT, 0.05% Nonidet P-40, 10 mM GTP, and 5 μCi 3H-
SAM (18 Ci/mmol, Perkin Elmer) at 30 °C or 39 °C. At various times,
20 μL samples were removed and spotted on DE81 ﬁlter paper
(Whatman). Unincorporated radioactivity was removed by wash-
ing with 0.5 M Na2HPO4. Radioactive GTP retained on the ﬁlter
was analyzed by liquid scintillation counting. Methyltransferase
activity of puriﬁed capping enzyme was assayed in identical
reactions except that virions were replaced with 162 ng puriﬁed
capping enzyme per 100 μL reaction.
T7 transcripts as methyl acceptor using puriﬁed CE
RNA, (GAGUU)11, was synthesized using T7 polymerase and
guanylylated using WT CE following the transguanylyation pro-
tocol described above. WT CE was deactivated by incubating
reactions at 60 °C for 5 min. Guanylylated RNA was isolated by
passage through three sequential 1 ml G-50 size exclusion col-
umns. WT or Dts36 CE was titrated in reactions containing 50 mM
Tris–HCl (pH 8), 2 mM DTT, 10 mM MgCl2, 680 nM guanylylated
RNA in the presence or absence of 50 μM SAM. Reactions were
incubated at 37 °C for 15 min. The 50 caps were cleaved off the RNA
with P1 nuclease in the presence of 0.1 M NaOAc (pH 5.5) at 50 °C
for 1 h. Products were resolved by PEI cellulose TLC in 0.7 M LiCl.
Thermoliability assays followed the above procedure with the
exception that WT CE and Dts36 CE were preincubated at 37 °C for
15 min.
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Template preparation for in vitro transcription assays
Ter29 is a synthetic DNA template (Fig. 10A) for in vitro early
gene transcription studies of vaccinia early genes (Deng et al.,
1996) generously provided by Dr. Edward Niles. The template
consists of a strong early gene promoter fused to a 20 base-pair
G-less cassette. The G-less cassette is followed by a 169 base-pair
of random sequence that begins with four G residues, and contains
a stretch of 9T residues beginning at þ29, which acts as the ter-
mination signal when transcribed into RNA. The Ter29 template
for in vitro transcription was generated by PCR ampliﬁcation of the
Ter29 plasmid using the M13 forward primer and the M13 reverse
primer with a biotin on the 50 end. The ampliﬁed linear double-
stranded templates were isolated using 1% agarose gels followed
by extraction using the Qiagen spin-column kit as per manu-
facturer's instructions. Puriﬁed templates were bound to strepta-
vidin coated paramagnetic beads (Promega) and stored in DEPC-
treated water at 4 °C.
pG8G is a synthetic DNA template (Fig. 10A) for in vitro inter-
mediate gene transcription (Condit et al., 1996). The template
consists of the G8R intermediate gene promoter fused to a 350
base-pair G-less cassette. The template was linearized by digestion
with HindIII. Linearized plasmid was isolated using 1% agarose gels
followed by extraction using the Qiagen spin-column kit as per
manufacturer’s instructions.
Early gene transcription termination assay
Transcription termination assays involved a two-step, pulse-
chase reaction as described previously (Hagler et al., 1994; Deng
et al., 1996). Step 1 of transcription was conducted with 1 mM ATP,
1 mM CTP, 5 mCi α32P-UTP (3000 Ci/mmol, Perkin Elmer), 100 fmol
template, and 0.5 μL of virion extract in transcription buffer
(20 mM Tris–HCl (pH 8), 6 mM MgCl2, 2 mM DTT, 8% glycerol).
Reactions were incubated at 30 °C for 15 min. This step results in
transcription initiation and elongation to the end of the G-less
cassette to yield stable transcription elongation complexes (TEC)
containing a 21 nucleotide radiolabeled transcript. TECs stalled at
G21 were washed three times in transcription buffer by drawing
aside the bead-bound templates with a magnet, removing the
reaction buffer and re-suspending the beads in transcription buf-
fer. Step 2 of transcription consisted of a 20 μL reaction containing
1 mM CTP, GTP, UTP and ATP in transcription buffer. Reactions
were incubated for 15 min at 30 °C. Where indicated, WT or Dts36
CE was added at the onset of Step 2 of transcription. Reactions
were stopped with 20 μL 95% formamide, boiled, and subjected to
denaturing PAGE. The resulting RNAs were visualized by auto-
radiography. Termination on the Ter29 template produces tran-
scripts of 75 nt, and ternary complexes that fail to terminate
yield 189 nt runoff transcripts. Percent termination was calculated
as the fraction of terminated transcripts in the supernatant com-
pared to the sum of the terminated transcripts and the read-
through transcripts.
Intermediate gene transcription assay
Intermediate transcription assays of WT or Dts36 CE activity
contained 0.8 mM ATP, 0.8 mM CTP, 6 μCi α32P-UTP, 10 μM UTP,
0.4 μg pG8G, 2 μg VITF-3 and 6 μg vaccinia RNA polymerase in
25 μL of transcription buffer (see above). (In our hands neither
VITF-1 nor the cellular factor are required for optimal intermediate
gene transcription in vitro. A manuscript detailing these observa-
tions is in preparation.) Reactions were incubated at 30 °C for
15 min and stopped with 25 μL of 95% formamide. Transcripts
were isolated by denaturing PAGE and visualized by auto-
radiography. In these reactions, which lack GTP, transcription stopswhen the TECs reach the end of the G-less cassette, yielding a
350 nt transcript.
Statistical analysis
For all graphs in which error bars are shown, the experiments
were repeated a minimum of three times and the values shown
represent averages plus and minus standard deviations.Acknowledgments
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